Mayo Researcher to Manage Oncology Alliance Data Center
Mayo Clinic biostatistician Daniel Sargent has been awarded a $32.7 million, five-year grant by the National Cancer Institute to lead the Alliance for Clinical Trials in Oncologys Statistics and Data Center. The Center will be located at the Mayo Clinic Cancer Center in Rochester, Minn.
Mayo Clinic biostatistician Daniel Sargent has been awarded a $32.7 million, five-year grant by the National Cancer Institute to lead the Alliance for Clinical Trials in Oncologys Statistics and Data Center. The Center will be located at the Mayo Clinic Cancer Center in Rochester, Minn.
This award will allow Mayo Clinic to continue and expand our over 35-year history as a national hub for conducting cancer clinical trials, Sargent said. The Alliance Statistics and Data Center is a multi-institutional operation that involves researchers at Mayo Clinic, Duke University, Dana-Farber Cancer Center, Ohio State University, and MD Anderson Cancer Center.
The Alliance is a national clinical trials network sponsored by the National Cancer Institute, consisting of nearly 10,000 cancer specialists throughout the U.S. and Canada. The group develops and conducts clinical trials on promising new cancer therapies, develops treatment and prevention strategies and conducts research to alleviate side effects of cancer and cancer treatments. The Alliance enrolls 3,000 to 5,000 patients annually in its studies.
This award will allow Mayo Clinic to continue and expand our over 35-year history as a national hub for conducting cancer clinical trials, Sargent said. The Alliance Statistics and Data Center is a multi-institutional operation that involves researchers at Mayo Clinic, Duke University, Dana-Farber Cancer Center, Ohio State University, and MD Anderson Cancer Center.
The Alliance is a national clinical trials network sponsored by the National Cancer Institute, consisting of nearly 10,000 cancer specialists throughout the U.S. and Canada. The group develops and conducts clinical trials on promising new cancer therapies, develops treatment and prevention strategies and conducts research to alleviate side effects of cancer and cancer treatments. The Alliance enrolls 3,000 to 5,000 patients annually in its studies.
More for you
Loading data for hdm_tax_topic #better-outcomes...